In this episode of Dosing Through the Downfall, Kelly Hanner exposes what she calls the piggy bank problem, how the FDA declared GLP-1 drug shortages “resolved,” shut down compounding access, and handed Big Pharma billions in cash profits.

We’ll trace the history of GLP-1 medications, from their quiet beginnings as diabetes drugs to today’s weight-loss frenzy and reveal how insurance pullbacks and FDA decisions left patients stuck paying out of pocket.

Then we’ll turn to hormones, why the “normal” lab ranges were designed to keep people sick, the dangers of living at the low end of normal, and how denying hormone replacement creates lifelong patients for the pharmaceutical machine.

Finally, Kelly shares how her approach is different: test, don’t guess; optimize, don’t normalize; and treat the whole person, not the profit margin.

🎙️ Tune in for a fiery episode that connects the dots between corruption, cash flow, and the fight for real health.

Enjoyed this episode?

• Follow Dynamic Minutes so you don’t miss what’s next
• Leave a review to help more people discover the podcast
• Share this episode with someone who may find it helpful

Connect with Dynamic Rejuvenation:

Instagram: @kelly.dynamicrejuvenation
Facebook: https://www.facebook.com/dynamicrejuvenation
YouTube: https://www.youtube.com/@DRwithKelly
Website and appointments: https://www.dynamicrejuvenation.biz

Better health starts with better questions. I’ll see you next time on Dynamic Minutes.